ZimVie (ZIMV) Set to Announce Quarterly Earnings on Wednesday

ZimVie (NASDAQ:ZIMV) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. ZimVie has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.

ZimVie (NASDAQ:ZIMV) last announced its earnings results on Wednesday, February 28th. The company reported $0.10 earnings per share for the quarter. The firm had revenue of $113.07 million during the quarter. ZimVie had a negative net margin of 51.33% and a positive return on equity of 2.44%.

ZimVie Price Performance

Shares of NASDAQ ZIMV opened at $15.80 on Monday. The firm has a market cap of $430.08 million, a PE ratio of -1.07 and a beta of 2.17. The company has a current ratio of 2.78, a quick ratio of 2.32 and a debt-to-equity ratio of 1.26. ZimVie has a 1-year low of $6.52 and a 1-year high of $20.91. The company has a fifty day moving average price of $16.64 and a 200 day moving average price of $14.88.

Analysts Set New Price Targets

Several brokerages have commented on ZIMV. Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a research report on Thursday, April 11th. Barclays upped their target price on shares of ZimVie from $13.00 to $16.00 and gave the company an “underweight” rating in a report on Tuesday, March 5th.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.